Outcomes after multiple courses of granulocyte colony-stimulating factor and growth hormone in decompensated cirrhosis: A randomized trial.
Nipun VermaAmritjyot KaurRatiram SharmaAshish BhallaNavneet SharmaArka DeVirendra SinghPublished in: Hepatology (Baltimore, Md.) (2018)
Multiple courses of G-CSF improved 12-month TFS, mobilized hematopoietic stem cells, improved disease severity scores, nutrition, fibrosis, QOL scores, ascites control, reduced infections, and the need for LT in patients with DC. However, the use of GH was not found to have any additional benefit. (Hepatology 2017).